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One sentence summary: 
The nuclear factor GDV1 induces gametocyte differentiation by activating expression of the 
master transcription factor AP2-G 
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Malaria is caused by Plasmodium parasites that proliferate in the bloodstream. During each 
replication cycle some parasites differentiate into gametocytes, the only forms able to infect 
the mosquito vector and transmit malaria. Sexual commitment is triggered by activation of 
AP2-G, the master transcriptional regulator of gametocytogenesis. Heterochromatin 
protein 1 (HP1)-dependent silencing of ap2-g prevents sexual conversion in proliferating 
parasites. Here, we identified Plasmodium falciparum gametocyte development 1 (GDV1) as 
an upstream activator of sexual commitment. We found that GDV1 targeted 
heterochromatin and triggered HP1 eviction thus de-repressing ap2-g. Expression of GDV1 
was responsive to environmental triggers of sexual conversion and controlled via a gdv1 
antisense RNA. Hence, GDV1 appears to act as an effector protein that induces sexual 
differentiation by antagonizing HP1-dependent gene silencing. 
Heterochromatin protein 1 (HP1) is a conserved regulator of heterochromatin formation, heritable 
gene silencing and variegated gene expression (1). In Plasmodium falciparum, HP1-dependent 
clonally variant expression allows parasites to adapt rapidly to environmental challenges 
encountered during infection (2-4). For example, immune evasion via antigenic variation of 
var/PfEMP1 is the hallmark of Plasmodium survival. Other processes, such as expression of red 
blood cell (RBC) invasion ligands or nutrient transporters, are similarly regulated in this parasite 
(4). Most clonally variant genes cluster in subtelomeric domains but some also occur in 
chromosome-internal heterochromatic regions. In addition, HP1 forms microdomains at some 
euchromatic genes (2). One of these encodes the transcription factor AP2-G that is required for 
sexual conversion and differentiation (2, 5-7). HP1-dependent regulation of ap2-g controls the 
rate at which parasites commit to sexual differentiation (7).   
To explore the mechanisms regulating HP1 occupancy in P. falciparum we identified HP1-
interacting proteins by liquid chromatography-tandem mass spectrometry (LC-MS/MS) analysis 
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of native HP1 complexes that were purified by co-immunoprecipitation (co-IP) from parasites 
expressing GFP-tagged HP1 (7) (Fig. 1A and Table S3). Interestingly, we consistently observed 
GDV1 among the potential HP1 interaction partners (Table S1). GDV1 is a nuclear protein 
implicated in sexual commitment and early gametocytogenesis but its exact function remains 
unknown (8). We therefore created a parasite line for the conditional expression of fluorescently 
labelled ectopic GDV1 (GDV1-GFP-DD) (Fig. 1B). Proteins tagged with the immunophilin 
protein-folding chaperone FKBP destabilisation domain (DD) are proteolytically degraded unless 
cells are cultured in presence of Shield-1, a small molecule ligand stabiliser (9, 10). Thus, GDV1-
GFP-DD is barely detectable in parasites cultured in absence of Shield-1 (3D7/GDV1-GFP-
DD
OFF
), but its expression is markedly induced in parasites grown in presence of Shield-1 
(3D7/GDV1-GFP-DD
ON
) (Fig. 1, B and C). In agreement with the co-IP results GDV1-GFP-DD 
co-localizes with HP1 at the nuclear periphery (Fig. 1C and Fig. S1). Furthermore, we found that 
recombinant HP1 and GDV1 formed a complex (Fig. S1) and that HP1 co-purified with GDV1-
GFP-DD in reverse co-IPs (Fig. 1D, Tables S2 and S4). The chromodomain-helicase-DNA-
binding protein 1 (CHD1) and a protein of unknown function (PF3D7_1451200) also consistently 
co-purified with both HP1 and GDV1-GFP-DD (Tables S1 and S2). Given that CHD1 plays 
important roles in cell fate decision and heterochromatin remodelling in other organisms (11, 12) 
and that GDV1 is implicated in gametocytogenesis (8) it appears that this putative regulatory 
complex may function in activating sexual commitment. 
Malaria parasites proliferate by iterative rounds of intra-erythrocytic replication through 
schizogony, merozoite release and RBC re-invasion. The decision to enter gametocytogenesis is 
made in the cell cycle prior to sexual differentiation; sexually committed schizonts release 
merozoites that invade RBCs and differentiate all into either female or male gametocytes (13, 14) 
(Fig. 2A). To test if GDV1 triggers sexual commitment, 3D7/GDV1-GFP-DD
OFF
 parasites were 
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split and cultured in the absence or presence of Shield-1. After re-invasion, stage I gametocytes 
were quantified by immuno-fluorescence assays (IFA) using antibodies against the gametocyte 
marker Pfs16 (15). Strikingly, the 3D7/GDV1-GFP-DD
ON
 population displayed a sexual 
conversion rate of 57.2% (+/- 10.0 SD) compared to 11.0% (+/- 2.4 SD) in 3D7/GDV1-GFP-
DD
OFF
 parasites, and these gametocytes differentiated normally into both male and female 
gametocytes and showed a typical female-biased sex ratio (Fig. 2B and Fig. S2). Moreover, 
Shield-1 titration revealed a positive correlation between ectopic GDV1-GFP-DD expression 
levels and sexual conversion rates (Fig. 2C). To test if endogenous GDV1 levels similarly 
correlate with gametocyte conversion we used CRISPR/Cas9-based gene editing to append a 
triple hemagglutinin (HA) tag to the N-terminus of GDV1 (3D7/3xHA-GDV1) (Fig. S3). 
Endogenous 3xHA-GDV1 co-localised with HP1 as expected (Fig. 2D and Fig. S3) but was only 
expressed in some parasites. We next quantified 3xHA-GDV1 expression under conditions that 
either suppress or favour sexual conversion. To this end, we made use of the recent discovery of 
choline as an inhibitor of sexual commitment (16). 3D7/3xHA-GDV1 parasites cultured in the 
presence or absence of 2 mM choline displayed sexual commitment rates of 1.8% (+/- 0.3 SD) or 
30.9% (+/- 3.8 SD), respectively (Fig. 2E). Strikingly, parasites cultured in the absence of choline 
showed markedly increased 3xHA-GDV1 expression levels (Fig. 2F). This was accounted for by 
a higher proportion of 3xHA-GDV1-positive cells (48.6% (+/- 3.4 SD) in absence compared to 
16.4% (+/- 1.8 SD) in presence of choline) (Fig. 2F) and comparatively higher 3xHA-GDV1 
expression levels in individual 3xHA-GDV1-positive parasites (Fig. S3). Together, these results 
show that GDV1 activates sexual conversion in a dose-dependent manner and that endogenous 
GDV1 expression can be induced by environmental signals triggering sexual commitment. 
We next performed comparative transcriptome analyses using two-colour microarrays. 
3D7/GDV1-GFP-DD
OFF 
ring stage parasites were split, cultured separately in absence or presence 
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of Shield-1 and total RNA was harvested at seven paired time points spanning the remaining 24 
hours of generation 1 (24-32 hours post-invasion (hpi); 32-40 hpi, 40-48 hpi) and the first 40 
hours after re-invasion in generation 2 (8-16 hpi, 16-24 hpi, 24-32 hpi, 32-40 hpi) (Fig. 2A). As 
expected, GDV1-GFP-DD expression triggered a transcriptional response characteristic of sexual 
commitment and early differentiation. This was evident from the induction of ap2-g in generation 
1, followed by activation of early gametocyte markers (5, 7, 8, 17) after re-invasion (Fig. 2G, Fig. 
S4 and Table S5). In F12 parasites, a 3D7-derived gametocyte-deficient clone carrying a loss-of-
function mutation in ap2-g (5, 18), GDV1-GFP-DD expression still activated ap2-g but failed to 
launch a sexual differentiation response (Fig. 2H and Table S6). Next to ap2-g only eight other 
genes were significantly induced in F12/GDV1-GFP-DD
ON
 parasites, all of which are marked by 
HP1. This set included dblmsp2, which was also induced in 3D7/GDV1-GFP-DD
ON 
parasites 
(Fig. 2, G and H). Given that DBLMSP2 is a merozoite surface antigen expressed only in a small 
subpopulation of schizonts (19, 20) the GDV1-dependent activation of the dblmsp2 locus 
suggests it may be expressed specifically in sexually committed schizonts. In summary, these 
findings show that GDV1 is an upstream activator of sexual commitment and likely triggers this 
process by antagonising HP1-dependent silencing of ap2-g. 
To test if GDV1 associates with heterochromatin in vivo we conducted comparative ChIP-seq 
experiments. 3D7/GDV1-GFP-DD
OFF
 parasites were split at 28-34 hpi, cultured in parallel in the 
absence or presence of Shield-1 and paired chromatin samples were harvested two (30-36 hpi), 
six (34-40 hpi) and ten (38-44 hpi) hours after Shield-1 addition. We found that (1) GDV1-GFP-
DD associates specifically with heterochromatin throughout the genome (Fig. 3A, Fig. S5, Table 
S7); (2) GDV1-GFP-DD occupancy was markedly higher in 3D7/GDV1-GFP-DD
ON
 compared to 
3D7/GDV1-GFP-DD
OFF
 parasites (Fig. S5, Table S7); and (3) GDV1-GFP-DD occupancy is 
highly correlated with that of HP1 (Fig. 3B). Moreover, GDV1-GFP-DD occupancy peaked six 
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hours post-induction and decreased substantially thereafter (Fig. 3A, Fig. S5, Table S7). This 
drop in GDV1-GFP-DD signal coincided with a reduced HP1 occupancy over heterochromatic 
genes in 3D7/GDV1-GFP-DD
ON
 compared to 3D7/GDV1-GFP-DD
OFF
 parasites (Fig. 3, A and C, 
Table S7). While the vast majority of heterochromatic loci, in particular those displaying high 
HP1 occupancy such as var genes, displayed only slightly decreased HP1 levels, some genes 
exhibited as much as 40% reduced HP1 occupancy (Fig. 3C and Table S7). This group of genes 
includes ap2-g and most known HP1-associated early gametocyte markers including geco (21), 
pfgexp17 (22) and pfg14_748 (8, 17) (Fig. 3, C and D, Table S7). These data are consistent with 
the microarray results, where GDV1-GFP-DD expression activated ap2-g and early gametocyte 
genes but had no effect on the expression of the bulk of heterochromatic loci including var genes 
(Fig. 2, G and H). Of note, given the 50-60% sexual conversion rate observed for 3D7/GDV1-
GFP-DD
ON
 parasites (see above), a 30-40% reduction in HP1 occupancy indicates that HP1 may 
be depleted at these loci specifically in sexually committed parasites but single cell approaches 
are required to confirm this hypothesis. Overall, we suggest that GDV1 destabilises 
heterochromatin and thus allows specific transcription factors to activate expression of ap2-g and 
other gametocyte-specific heterochromatic genes, and this may play an important role in the 
positive auto-regulatory feedback loop proposed to reinforce AP2-G expression in committed 
parasites (5, 6, 23). How GDV1 achieves specificity in unlocking specific HP1-associated genes 
despite binding heterochromatin genome-wide is a challenging question to be addressed in the 
future.  
Since GDV1 activates sexual commitment, the question arises of how parasites limit GDV1 
expression to prevent sexual conversion in asexual schizonts. A recent study identified a multi-
exon long non-coding gdv1 antisense RNA (asRNA) that initiates downstream of the gdv1 locus 
and overlaps with the ATG start codon of gdv1 (24), which is a hallmark feature of regulatory 
7 
 
asRNAs (25). To investigate if the gdv1 asRNA participates in regulating sexual commitment we 
created a gdv1 asRNA loss-of-function mutant in F12 parasites (F12/gdv1-asKO) (Fig. 4A and 
Fig. S6). Strand-specific RNA-seq analysis identified a small set of genes that were consistently 
differentially expressed between F12/gdv1-asKO and F12 wild-type parasites (17 up- and 23 
down-regulated genes) (Fig. 4B, Table S8). Strikingly, and similar to F12 parasites expressing 
ectopic GDV1-GFP-DD (Fig. 2H), ap2-g, dblmsp2 and two early gametocyte genes (pfg14_748, 
PF3D7_1477400) (8, 17) were markedly induced in F12/gdv1-asKO parasites, and all except one 
up-regulated gene are HP1-associated genes (Fig. 4B, Fig. S6, Table S8). gdv1 sense transcripts 
were slightly increased in the F12/gdv1-asKO population, while gdv1 antisense transcripts were 
undetectable as expected (Fig. 4, B and C, Fig. S6, Table S8). These results indicated that the 
gdv1 asRNA acts as a negative regulator of GDV1 expression. To confirm this hypothesis, we 
tagged endogenous GDV1 in these parasites (F12/3xHA-GDV1/gdv1-asKO) and observed that 
indeed almost all parasites expressed 3xHA-GDV1 (96.7% +/- 2.5 SD) (Fig. S7). Lastly, we 
show that deletion of the gdv1 asRNA locus in a conditional AP2-G mutant resulted in a 
markedly increased production of gametocytes (Fig. S8 and Supplementary text). Together, these 
findings demonstrate a central role for the gdv1-asRNA in regulating GDV1-dependent activation 
of sexual commitment. We anticipate this mechanism likely involves inhibiting GDV1 
expression by interference with gdv1 mRNA transcription, stability or translation, similar to 
asRNA-mediated gene regulation in other organisms (26). 
We identified GDV1-mediated heterochromatin destabilisation as an epigenetic control strategy 
regulating sexual cell fate decision in P. falciparum. Our discovery of the gdv1-asRNA as a 
negative regulator of sexual commitment is reminiscent of lncRNA-mediated control of 
gametogenesis in yeasts (27, 28). In S. cerevisiae, nutritional stress triggers gametogenesis by 
activating the transcriptional regulator Inducer of Meiosis 1 (IME1) (28). A lncRNA in the ime1 
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promoter and antisense transcription of ime4 are key factors in preventing IME1 expression under 
non-inducing conditions (29, 30). These parallels raise the exciting possibility that evolutionary 
divergent unicellular eukaryotes may employ a conceptually similar regulatory logic to control 
entry into the sexual phases of their life cycles. Interestingly, all Plasmodium species infecting 
humans possess a GDV1 ortholog suggesting the GDV1-based regulation of sexual commitment 
is conserved in all human-infective malaria parasites. In conclusion, our study contributes to 
understanding the molecular pathway underlying the formation of malaria transmission stages 
and provides opportunities for the development of intervention strategies targeting transmission 
of human malaria. 
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Fig. 1. GDV1 interacts with HP1. (A) Endogenous hp1 locus in 3D7/HP1-GFP parasites and -
HP1 Western blots of the -HP1-GFP co-IP and negative control samples. Results are 
representative of three biological replicates. (B) gdv1-gfp-dd expression plasmid and -GFP 
Western blots of 3D7/GDV1-GFP-DD
OFF
 and 3D7/GDV1-GFP-DD
ON
 parasites. -HP1 
antibodies served as loading control. (C) GDV1-GFP-DD/HP1 co-localisation IFAs in 
3D7/GDV1-GFP-DD
OFF
 and 3D7/GDV1-GFP-DD
ON
 trophozoites (24-32 hpi). DIC, differential 
interference contrast. Scale bar, 2.5 m (0.5 m for the magnified views in the rightmost 
images). Results are representative of three biological replicates. (D) -GFP and -HP1 Western 
blots of the -GDV1-GFP-DD co-IP and negative control samples. Results are representative of 
three biological replicates. 
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Fig. 2. GDV1 induces sexual commitment and differentiation. (A) Schematic illustrating the 
iterative cycles of schizogony and RBC re-invasion (top) or sexual commitment, RBC re-
invasion and gametocyte differentiation (bottom). ER/LR, early/late ring stages; T, trophozoites; 
ES/LS, early/late schizonts; gen, generation; hpi, hours post-invasion; asterisk, time point of -
Pfs16 IFAs. (B) Top panel: -Pfs16 IFAs identifying stage I gametocytes. Quantification of 
Pfs16-positive parasites is shown at the right (results are the mean of three biological replicates 
(200 infected RBCs counted per sample); error bars indicate SD). Bottom panel: Giemsa-stained 
blood smears showing stage V gametocytes. Scale bars, 5 m. (C) Western blot showing GDV1-
GFP-DD expression in presence of increasing Shield-1 concentrations. -GAPDH and -HP1 
antibodies served as loading controls. Percentages of Pfs16-positive parasites are shown at the 
bottom (400 infected RBCs counted per sample). (D) Endogenous gdv1 locus in 3D7/3xHA-
GDV1 parasites and 3xHA-GDV1/HP1 co-localisation IFAs in trophozoites (24-32 hpi). Scale 
bar, 2.5 m. (E) Sexual conversion rates in 3D7/3xHA-GDV1 parasites cultured in presence or 
absence of choline (results are the mean of three biological replicates (>190 infected RBCs 
counted per sample); error bars indicate SD). (F) Left panel: Western blot showing 3xHA-GDV1 
expression levels in 3D7/3xHA-GDV1 parasites cultured in presence or absence of choline. -
HP1 antibodies served as loading control. Right panel: Percentages of 3xHA-GDV1-positive 
parasites in presence or absence of choline (results are the mean of three biological replicates 
(>100 infected RBCs counted per sample); error bars indicate SD). (G,H) Comparison of mean 
expression levels of all genes in 3D7/GDV1-GFP-DD
ON 
versus 3D7/GDV1-GFP-DD
OFF 
(G) and 
F12/GDV1-GFP-DD
ON 
versus F12/GDV1-GFP-DD
OFF
 parasites (H). Significantly de-regulated 
genes are indicated by circles (mean fold change cut-off >1.5; q-value (fdr) cut-off <0.15). 
Known early gametocyte markers (7, 8, 17) are labelled orange. Line graphs show fold changes 
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in expression across seven consecutive TPs. pfs16/pfg27/gexp02, early gametocyte markers (15, 
22, 32); pk4 (PF3D7_0628200)/glu-tRNA-l. (PF3D7_1331700), control genes (7). 
 
 
Fig. 3. GDV1 associates with heterochromatin throughout the genome and triggers HP1 
removal at ap2-g. (A) HP1 over input ratio track from 3D7/GDV1-GFP-DD
OFF
 schizonts (38-
44 hpi, TP3) (grey). ChIP-seq subtraction tracks display relative enrichment of GDV1-GFP-
DD in 3D7/GDV1-GFP-DD
ON
 schizonts two (30-36 hpi, TP1), six (34-40 hpi, TP2) and ten (38-
44 hpi, TP3) hours after Shield-1 addition (blue), and relative depletion of HP1 in 3D7/GDV1-
GFP-DD
ON
 parasites at TP3 (green). (B) Correlation between GDV1-DD-GFP enrichment in 
3D7/GDV1-GFP-DD
ON
 (34-40 hpi, TP2) and HP1 enrichment in 3D7/GDV1-GFP-DD
OFF
 
schizonts at each coding region. r, Pearson correlation coefficient. (C) Fold change in HP1 
enrichment upon GDV1-GFP-DD overexpression in relation to HP1 enrichment in 3D7/GDV1-
GFP-DD
OFF
 schizonts for each heterochromatic gene. (D) Zoom-in view of the 
enrichment/subtraction tracks at the ap2-g locus. 
19 
 
 
Fig. 4. A gdv1 antisense RNA antagonises GDV1-dependent sexual commitment. (A) gdv1 
locus in F12 wild-type and F12/gdv1-asKO parasites. The gdv1 sense transcript (blue), five-exon 
gdv1-asRNA (24) (red) and hdhfr resistance marker (brown) are highlighted. (B) Comparison of 
gene expression levels in F12
 
wild-type and F12/gdv1-asKO
 
early (ES) and late (LS) schizonts. 
Genes de-regulated > 5-fold in both TPs are indicated by circles. (C) UCSC genome browser 
screenshots of RNA-seq coverage plots over the gdv1 locus in F12
 
wild-type and F12/gdv1-asKO
 
early (ES) and late (LS) schizonts. The hdhfr resistance cassette downstream of the gdv1 locus in 
F12/gdv1-asKO parasites and absent in the 3D7 reference genome is indicated by a brown box. 
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(D) Endogenous gdv1 locus in F12/3xHA-GDV1/gdv1-asKO parasites and -HA overview IFA 
in early schizonts (ES, 32-40 hpi). DIC, differential interference contrast. Scale bar, 5 m. 
Percentage of 3xHA-GDV1-positive parasites is shown at the right (results are the mean of three 
biological replicates (100 infected RBCs counted per sample); error bars indicate SD). 
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SUPPLEMENTAL MATERIALS 
 
 
Materials and Methods 
 
Parasite culture, transfection constructs and transgenic cell lines 
P. falciparum 3D7 and F12 parasites were cultured as described (33). Growth 
synchronization was achieved by repeated sorbitol treatments (34). To generate parasite lines 
3D7/GDV1-GFP-DD and F12/GDV1-GFP-DD expressing ectopic GDV1-GFP-DD, the gdv1 
coding sequence (primers gdv1_pHGFPDD_BamHI and gdv1_pHGFPDD_NotI) was cloned in 
frame with gfp-dd into pHcamGFP-DD using BamHI and SalI. pHcamGFP-DD was obtained by 
inserting a PCR fragment encoding the FKBP destabilizing domain (DD) in frame with gfp into 
SpeI/SalI-digested pHcamGFP (35). 3D7 and F12 parasites were transfected with pHcamGDV1-
GFP-DD and selected with 4nM WR99210 (WR) as described (36). Induction of GDV1-GFP-
DD expression was achieved by addition of 312.5 nM Shield-1 to the culture medium unless 
otherwise indicated. 
We generated three new mother plasmids (p_gC, pH_gC and pB_gC) for CRISPR/Cas9-
based genome engineering in P. falciparum using the following cloning steps. First, plasmid 
pgRNA was obtained by Gibson assembly joining the NcoI/PvuII fragment containing the 
plasmid backbone and U6 single guide RNA (sgRNA) expression cassette of pL-6_eGFP (37) 
with a PCR fragment containing a HindIII-SalI-EcoRI-BamHI multi-cloning site (MCS) 
amplified from pET-32a(+) using primers PCR1_F and PCR1_R. In a second step, the BsaI site 
in the amp
R
 gene in pgRNA was eliminated using a Gibson assembly reaction by replacing the 
207 bp BsaI/FspI amp
R
 fragment with a corresponding 207 bp PCR fragment obtained with 
primers PCR2_F and PCR2_R, the latter of which introduced a silent G to A mutation in the BsaI 
recognition sequence (GGTCTC to GATCTC). This plasmid was named pgRNA2. In a third 
step, the BtgZI recognition site in the U6 sgRNA expression cassette in pgRNA2 was replaced 
with a BsaI recognition sequence to obtain pgRNA3. To achieve this, the BtgZI-digested 
pgRNA2 plasmid and a 56 bp fragment obtained by annealing the two complementary 
oligonucleotides BsaI_F and BsaI_R were joined by Gibson assembly. In a forth step, a Cas9 
expression cassette was introduced into pgRNA3 using Gibson assembly to obtain the mother 
plasmid p_gC. Here, NcoI-digested pgRNA3 was joined with three PCR fragments amplified 
from pUF1_Cas9 (37) encoding (1) the P. falciparum hsp86 promoter (primers PCR4a_F and 
PCR4a_R), (2) Streptococcus pyogenes Cas9 (primers PCR4b_F and PCR4b_R), and (3) the P. 
berghei dhfr-ts terminator (primers PCR4c_F and PCR4c_R). In the fifth step, a human 
dihydrofolate reductase (hDHFR) resistance cassette was introduced into p_gC by Gibson 
assembly to obtain the mother plasmid pH_gC. This was achieved by assembling the BamHI-
digested p_gC with three PCR fragments encoding (1) the P. falciparum cam promoter amplified 
from 3D7 gDNA (primers PCR5a_F and PCR5b_R), (2) the hdhfr gene amplified from 
pL6_eGFP (primers PCR5b_F and PCR5b_R), and (3) the P. falciparum hrp2 terminator 
amplified from pL6_eGFP (primers PCR5c_F and PCR5c_R). The mother plasmid pB_gC is a 
modified version of pH_gC where the hDHFR cassette is replaced with a blasticidin deaminase 
(BSD) resistance cassette using Gibson assembly. This was achieved by assembling 
BamHI/XhoI-digested pH_gC with three PCR fragments representing (1) the cam promoter 
amplified from pH_gC with primers B1F and B1R; (2) the bsd gene amplified from 
pBcam_3xHA (2) using primers B2F and B2R; and (3) the hrp2 terminator amplified from 
pH_gC using primers B3F and B3R. We also generated pHF_gC and pBF_gC, modified versions 
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of pH_gC and pB_gC, respectively, expressing hDHFR fused to the bifunctional negative 
selection marker yeast cytosine deaminase/uridyl phosphoribosyl transferase (hDHFR-yFCU) 
instead of hDHFR alone. For pHF_gC, pH_gC was digested with XhoI and XbaI (cuts within 
hdhfr) and assembled with four PCR products: (1) the 3’ end of hdhfr starting at the XbaI site 
amplified from pH_gC using primers HF1F and HF1R; (2) the 5’ part of yfcu up to the internal 
BamHI site amplified from pL6-eGFP (37) using primers HF2F and HF2R; (3) the 3’ part of yfcu 
starting at the internal BamHI site amplified from pL6-eGFP (37) using primers HF3F and HF3R 
(note that the separation of the yfcu sequence into two parts was required to eliminate the internal 
BamHI site); and (4) the hrp2 terminator amplified from pH_gC using primers HF4F and B3R. 
For pBF-gC, the BamHI/XhoI-digested pB_gC vector was assembled with two PCR products: (1) 
the cam promoter and bsd coding sequence amplified from pB_gC using primers B1F and BF1R; 
and (2) the yfcu coding sequence and hrp2 terminator amplified from pHF_gC with primers 
HF2F and B3R. The mother plasmid p_gC serves as a template to generate CRISPR/Cas9 
knockout plasmids (single plasmid approach), and the pH_gC, pB_gC, pHF_gC and pBF_gC 
mother plasmids are used together with a donor plasmid for gene tagging. 
To generate 3D7/AP2-G-GFP-DDglmS parasites we constructed the CRISPR/Cas9 
transfection vector pH_gC-ap2g-3’-gfp-dd-glmS allowing for marker-free genome editing using a 
single plasmid. We first generated plasmid pH_gC-ap2g-3’ by inserting two annealed 
complementary oligonucleotides (sgt_ap2g3’_F, sgt_ap2g3’_R) encoding the sgRNA target 
sequence sgt_ap2-g-3’ and appropriate single-stranded overhangs into the sgRNA expression 
cassette in pH_gC using BsaI digestion and T4 DNA ligase. The sgRNA target sequence 
sgt_ap2g3’ (agttatagggaatattcaaa) is positioned 60 bp downstream of the ap2-g coding sequence 
and was identified using CHOPCHOP  (38, 39). We then generated a second plasmid carrying an 
ap2g-gfp-dd-glmS donor assembly (pD_ap2g-gfp-dd-glmS) using two subsequent cloning steps. 
First, plasmid pD_ap2g-gfp was generated using Gibson assembly joining four PCR fragments 
encoding (1) the plasmid backbone amplified from pUC19 using primers PCRA_F and PCRA_R, 
(2) a 393 bp ap2-g 5’ homology box (HB) (spanning bps 6904-7296 of the ap2-g gene) amplified 
from 3D7 gDNA using primers PCRB_F and PCRB_R, (3) the gfp coding sequence (plus N-
terminal GSAG linker) amplified from pH-GFP (7) using primers PCRC_F and PCRC_R, and (4) 
a 670 bp ap2-g 3’ HB (spanning the region 60-730 bp downstream of the ap2-g gene) amplified 
from 3D7 gDNA using primers PCRD_F and PCRD_R. Second, pD_ap2g-gfp-dd-glmS was 
constructed using Gibson assembly of three PCR fragments representing (1) the ap2-g 5’ 
HB/pUC19 backbone/ap2-g 3’ HB assembly amplified from pD_ap2g-gfp using primers 1F and 
1R, (2) the gfp-dd sequence amplified from pH-GFP-DD (7) using primers 2F and 2R, and (3) the 
glmS-246 sequence amplified from pL6-3HA_glmS-246 (kind gift from Dave Richard) using 
primers 3F and 3R. The final CRISPR/Cas9 transfection vector pH_gC-ap2g-3’-gfp-dd-glmS was 
then obtained by introducing the EcoRI/HindIII-digested ap2g-gfp-dd-glmS donor assembly 
amplified from pD_ap2g-gfp-dd-glmS (primers EcoF and HindR) into EcoRI/HindIII-digested 
pH_gC-ap2g-3’. The pH_gC-ap2g-3’-gfp-dd-glmS construct was transfected into 3D7 parasites 
and 3D7/AP2-G-GFP-DDglmS parasites were selected with 4 nM WR and 2.5 mM (D)-+-
glucosamine (GlcN) (Sigma Aldrich) for six days and then maintained in absence of WR until a 
stably propagating parasite population was established. Successful editing of the ap2-g locus was 
confirmed by PCR on gDNA. Stabilisation of AP2-G-GFP-DD expression was achieved by 
removing GlcN and adding 1350 nM Shield-1 to the culture medium. 
To disrupt the antisense RNA locus downstream of the gdv1 coding sequence in F12 wild-
type and 3D7/AP2-G-GFP-DDglmS parasites we generated the CRSIPR/Cas9 knockout vectors 
p_gCH-gdv1-asKO and p_gCB-gdv1-asKO, respectively. First, p_gC-gdv1-asKO-pre was 
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created by inserting a hdhfr resistance cassette flanked by the 5’ and 3’ HBs into p_gC using 
Gibson assembly. This was achieved by assembling EcoRI/HindIII-digested p_gC with three 
PCR fragments encoding (1) a 440 bp 5’ HB amplified from 3D7 gDNA (spanning the last 93 bp 
of the gdv1 coding sequence and 347 bp of the downstream sequence; primers p_gC-gdv1-
asKO_5‘HB_for and p_gC-gdv1-asKO_5‘HB_rev), (2) a hdhfr resistance cassette amplified from 
pH_gC (primers p_gCH-gdv1-asKO_hdhfr_for and p_gCH-gdv1-asKO_hdhfr_rev), and (3) a 
753 bp 3’ HB amplified from 3D7 gDNA (spanning the region 3,554-4,307 bp downstream of the 
gdv1 coding sequence; primers p_gCH-gdv1-asKO_3‘HB_for and p_gCH-gdv1-
asKO_3‘HB_rev). To generate the final p_gCH-gdv1-asKO construct, the two complementary 
oligonucleotides (sgt_gdv1-3’_F and sgt_gdv1-3’_R) encoding the sgRNA target sequence 
sgt_gdv1-3’ and appropriate single-stranded overhangs were annealed and inserted into the 
sgRNA expression cassette using BsaI-digested p_gC-gdv1-asKO-pre and T4 DNA ligase. The 
sgRNA target sequence sgt_gdv1-3’ (tgtattactaaagaatgaaa) is positioned 1,639 bp downstream of 
the gdv1 coding sequence and was identified using CHOPCHOP (38, 39). For the p_gCB-gdv1-
asKO construct, p_gCH-gdv1-asKO was cut with XhoI and EcoRI to release the hdhfr resistance 
cassette and the 3’ HB. Gibson assembly was then used to insert PCR fragments encoding the 
blasticidin deaminase (bsd) resistance cassette amplified from pB_gC (primers p_gCB-gdv1-
asKO_for and p_gCB-gdv1-asKO_rev) and the identical 753 bp 3’HB amplified from 3D7 
gDNA (primers p_gCB-gdv1-asKO_3‘HB_for and p_gCB-gdv1-asKO_3‘HB_rev). The p_gCH-
gdv1-asKO construct was transfected into F12 parasites and F12/gdv1-asKO parasites were 
selected with 4 nM WR. The p_gCB-gdv1-asKO construct was transfected into 3D7/AP2-G-
GFP-DDglmS parasites grown in presence of 2.5 mM GlcN and 3D7/AP2-G-GFP-
DDglmS/gdv1-asKO parasites were selected with 2.5 µg/ml blasticidin-S-HCl (BSD). Successful 
disruption of the gdv1-asRNA locus and replacement with the hdhfr or bsd resistance cassettes 
was confirmed by PCR on gDNA. Stabilisation of AP2-G-GFP-DD expression was achieved by 
removing GlcN and adding 1350 nM Shield-1 to the culture medium. 
To create the 3D7/3xHA-GDV1 and F12/3xHA-GDV1/gdv1-asKO parasite lines we 
prepared the CRISPR/Cas9 transfection vectors pB_gC-gdv1-5’ and the donor plasmid 
pFDon_3xha-gdv1. pFDon contains an expression cassette for yfcu under control of the hsp86 
promoter and was cloned by Gibson assembly of four PCR fragments: (1) the pUC18 E. coli 
plasmid backbone amplified with primers D1F and D1R; (2) the hsp86 promoter amplified from 
pHF_gC using primers D2F and D2R; (3) the yfcu coding sequence and hrp2 terminator 
amplified from pHF_gC using primers D3F and D3R; and (4) the MCS amplified from pHF_gC 
using primers D4F and D4R. To obtain pFDon_3xha-gdv1, three PCR fragments were inserted 
into the pFDon plasmid by Gibson assembly: (1) a 5’ HB spanning 504 bp of the gdv1 upstream 
region (-505 to -1) amplified from 3D7 gDNA (primers pFDon_GDV1_HA_for and 
pFDon_GDV1_HA_rev); (2) a 93 bp fragment coding for a 3xHA-tag amplified from 
pBcam_3xHA (2) (primers pFDon_GDV1_HA_HAtag_for and 
pFDon_GDV1_HA_HAtag_rev); and (3) a 3’ HB spanning 488 bp of the gdv1 coding region (+3 
to +491) amplified from 3D7 gDNA. The 3’ HB fragment was created in a two-step process. 
First, a fragment containing three mismatch mutations in the sgRNA target sequence sgt_gdv1-5’ 
(tgaaagtaaaaggtaatagt to tgaaGgtTaaaggCaatagt) was amplified from 3D7 gDNA (primers 
pFDon_GDV1_HA_3’HB_mut_for and pFDon_GDV1_HA_3’HB_mut_rev). This sequence was 
then used as template for a second round of amplification adding overhangs for Gibson assembly 
(primers pFDon_GDV1_HA_3’HB_for and pFDon_GDV1_HA_3’HB_rev). To create the 
pB_gC-gdv1-5’ CRISPR/Cas9 plasmid two complementary oligonucleotides (sgt_gdv1-5’_F and 
sgt_gdv1-5’_R) encoding the sgRNA target sequence sgt-gdv1-5’ (tgaaagtaaaaggtaatagt; 
24 
 
positioned 28 bp downstream of the start codon of the gdv1 coding sequence) were annealed and 
inserted into the BsaI site in pB_gC. Equal amounts of both plasmids were transfected into 3D7 
wild-type and F12/gdv1-asKO parasites and 3D7/3xHA-GDV1 and F12/3xHA-GDV1/gdv1-
asKO parasites were selected with 5 µg/ml BSD for 10 days and then maintained in absence of 
drug pressure until stably propagating parasite populations were established. Successful editing 
of the gdv1 locus was confirmed by PCR on gDNA. The 3D7/3xHA-GDV1 line was cloned out 
as described (40). 
All oligonucleotide sequences used for cloning and confirmation of CRISPR/Cas9-based 
gene editing by PCR are provided in Table S9. 
  
Preparation of parasite nuclear extracts 
Nuclei were isolated as described (41). Prior to nuclear protein extraction, nuclei were 
treated with DNase I and RNAse A (20mM Hepes pH 7.4, 10mM NaCl, 5mM MgCl2, 1mM 
CaCl2, 0.1% NP-40, 1x protease inhibitor (Roche Diagnostics), 1x PhosSTOP (Roche 
Diagnostics), 0.5 U/l DNase I (Roche Diagnostics), 1g RNase A (Roth)) in a 250 l reaction 
for 5min at 37°C. Reactions were adjusted to 500 l using 2x high salt extraction buffer (20mM 
Hepes pH 7.4, 1M NaCl, 6mM EDTA, 2mM EGTA, 2mM TCEP, 1x protease inhibitor (Roche 
Diagnostics), 1x PhosSTOP (Roche Diagnostics), 50% Glycerol, 0.1%NP-40) and nuclear 
proteins were extracted in 2.5 pellet volumes high salt extraction buffer (20mM Hepes pH 7.4, 
500mM NaCl, 3mM EDTA, 1mM EGTA, 1mM TCEP, 1x protease inhibitor (Roche 
Diagnostics), 1x PhosSTOP (Roche Diagnostics), 25% Glycerol, 0.1%NP-40) containing 
0.02mg/ml H3K9me3 peptides (Diagenode) and incubated at 4°C for 1 h. After centrifugation at 
20800g at 4°C for 30min supernatants were immediately used for co-IP experiments. 
 
Co-Immunoprecipitation (co-IP) 
High salt nuclear extract from 3D7/HP1-GFP or 3D7/GDV1-GFP-DD
ON
 schizonts was 
diluted to 250mM NaCl using dilution buffer (20mM Hepes pH 7.4, 1mM EDTA, 1mM TCEP, 
1x protease inhibitor (Roche Diagnostics), 1x PhosSTOP (Roche Diagnostics), 25% Glycerol) 
and incubated with negative control agarose beads (Chromotek) for 30 min at 4°C under constant 
agitation for lysate pre-clearing. The supernatant was split and incubated with GFP-Trap agarose 
beads (Chromotek) or negative control agarose beads (Chromotek) for 1 h at 4°C under constant 
agitation. The supernatant was recovered and beads were washed four times in wash buffer 1 
(20mM Hepes pH 7.4, 250mM NaCl, 1mM EDTA, 1mM TCEP, 0.05% NP-40) and once in wash 
buffer 2 (20mM Hepes pH 7.4, 250mM NaCl, 1mM EDTA, 1mM TCEP) . Bound proteins were 
eluted for 1 h at RT under constant agitation using 2M arginine buffer (2M arginine, pH 4) 
followed by a second elution in 2% SDS buffer (2% SDS, 20mM Tris-HCl, pH 8) for 10 min at 
95°C. All centrifugation steps were performed at 4°C for 3 min at 500g. Samples were analysed 
by Western blot using mouse mAb GFP (Roche Diagnostics #11814460001) or rabbit 
PfHP1 (7) antibodies.  
 
Capillary liquid chromatography-tandem mass spectrometry (LC-MS/MS) 
For the HP1 co-IP experiments, both the 2M arginine elution and the 2% SDS elution were 
analysed by LC-MS/MS. For the GDV1-GFP-DD co-IP experiments only the 2% SDS elution 
samples were analysed. Proteins in the 2M arginine elution buffer were reduced with 10 mM 
DTT at 37°C for 1 hr and alkylated with 50 mM iodo-acetamide for 15 min at room temperature. 
Proteins were digested with 250 ng endoproteinase LysC (Wako, Neuss, Germany) for two hours 
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at 37°C followed by 500 ng trypsin (Worthington, Lakewood, NJ, USA) overnight. The digest 
was stopped with 1% TFA and desalted on a microspin column (The Nest Group, Southborough, 
MA, USA) according to the manufacturer’s recommendations. Proteins eluted with 2% SDS were 
precipitated with 10% TCA, washed twice in ice-cold acetone and air-dried. The protein pellets 
were dissolved in 30 l 100 mM Tris-HCl (pH 8.0)/6M Urea, containing 10 mM DTT and 
reduced, alkylated and digested with 250 ng endoproteinase LysC as above. The urea 
concentration was diluted to 2 M with 100 mM Tris-HCl (pH 8.0) and the sample was further 
digested with 500 ng trypsin overnight at 37°C. The digest was acidified with 1% TFA and the 
sample was desalted on a MicroSpin cartridge.  
The peptides were dried in a SpeedVac and dissolved in 40 L 0.1% formic acid and 
analysed by capillary liquid chromatography tandem MS (LC-MS/MS) using a home-packed 
separating column (0.075 mm x 15 cm) packed with Reprosil C18 reverse-phase material (2.4 m 
particle size, Dr. Maisch, Ammerbuch-Entringen, Germany). The column was connected on line 
to an Orbitrap Elite FT hybrid instrument (Thermo Scientific, Reinach, Switzerland). The 
solvents used for peptide separation were 0.1% formic acid in water/0.005% TFA (solvent A) and 
0.1% formic acid/0.005% TFA and 80% acetonitrile in water (solvent B). 2 l of peptide digest 
were injected with a Proxeon nLC capillary pump (Thermo Scientific) set to 0.3 l/min. A linear 
gradient from 0 to 40% solvent B in solvent A in 95 min was delivered with the nano pump at a 
flow rate of 300 nl/min. After 95 min the percentage of solvent B was increased to 75% in ten 
minutes. The eluting peptides were ionized at 2.5 kV. The mass spectrometer was operated in 
data-dependent mode. The precursor scan was done in the Orbitrap set to 60,000 resolution, while 
the fragment ions were mass analyzed in the LTQ instrument. A top twenty method was run so 
that the twenty most intense precursors were selected for fragmentation. The MS/MS spectra 
were searched against a combined P. falciparum (www.plasmoDB.org; release 11.1)/human 
annotated protein database using Proteome Discoverer 1.4 (Thermo Scientific, Reinach, 
Switzerland) using the two search engines Mascot and SequestHT (Tables S3 and S4). For the 
search, oxidized methionine and N-terminal protein acetylation were used as variable 
modifications. The identifications were filtered to a peptide false discovery rate of 1%. 
 
Fluorescence microscopy 
IFAs were performed with methanol-fixed or 4% formaldehyde/0.0075% glutaraldehyde-
fixed cells using the following primary antibodies: mouse mAb GFP (Roche Diagnostics 
#11814460001), 1:100; rat mAb HA (3F10, Roche Diagnostics #11867423001), 1:100; rabbit 
PfHP1 (7), 1:200; mouse mAb Pfs16 (kind gift from Robert W. Sauerwein), 1:500. 
Secondary antibodies: Alexa Fluor 568-conjugated rabbit IgG (Molecular Probes #A11011), 
1:500; Alexa Fluor 488-conjugated rabbit IgG (Molecular Probes #A11008), 1:500; Alexa 
Fluor 488-conjugated mouse IgG (Molecular Probes #A11001), 1:500; Alexa Fluor 488-
conjugated rat IgG (Molecular Probes #A11006), 1:250; Alexa Fluor 568-conjugated rat 
IgG (Molecular Probes #A11077), 1:250. Nuclei were stained with DAPI. Images were taken on 
a Leica DM 5000B microscope with a Leica DFC 345 FX camera, acquired via the Leica IM1000 
software, and processed using Fiji (42). For each experiment, images were acquired and 
processed with identical settings. 
 
Western Blot 
Parasites were released from infected RBCs by saponin lysis, resuspended in 8M Urea, 
5%SDS, 40mM Tris pH 6.8, 1% β-Mercaptoethanol, 1x protease inhibitor (Roche Diagnostics) 
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and separated on NuPage 4-12% Bis-Tris gels (Novex). Proteins were detected with mouse mAb 
GFP (Roche Diagnostics #11814460001), 1:500; rabbit PfHP1 (7), 1:5’000; mouse mAb 
PfGAPDH (43), 1:20’000; rat mAb HA (3F10, Roche Diagnostics #11867423001), 
1:10’000; mouse mAb -6xHIS (R&D Systems #MAB050R), 1:5’000.    
 
In vitro protein-protein interaction experiments 
A plasmid vector with the following expression cassette was constructed for co-expression of 
HP1 and GDV1: T7 promoter/strep(II)-hp1/T7 promoter/6xhissumo-gdv1/T7 terminator (pStrep-
HP1_HS-GDV1). We used pETA-HS and pETA-Strep as parental vectors, which we previously 
constructed for the expression of N-terminal 6xHis-SUMO-tagged and N-terminally Strep(II)-
tagged fusion proteins, respectively. pETA-HS was obtained by introducing a sequence encoding 
a 6xHis stretch followed by Saccharomyces cerevisiae SUMO (amplified from gDNA using 
primers SUMO_F and SUMO_R between the NdeI and BamHI sites of pET20(b)+ (Novagen), 
yielding a vector similar to the one described elsewhere (44). pETA-Strep was generated by 
replacing the NdeI/BamHI fragment in pET20b(+) with an annealed double-stranded 
oligonucleotide (Strep_F and Strep_R) encoding Met-Ala-Ser-Strep(II). The co-expression 
plasmid pStrep-HP1_HS-GDV1 was cloned by Gibson assembly of four PCR products 
representing (1) the backbone of pETA-Strep amplified using the primers SF and SR; (2) the hp1 
coding sequence (cds) starting at +4 amplified from 3D7 gDNA using primers HP1F and HP1R; 
(3) the T7 promoter and the sequence encoding the 6xHis-SUMO tag amplified from pETA-HS 
with primers HSF and HSR; and (4) the gdv1 cds starting at +4 amplified from 3D7 gDNA using 
primers GDV1F and GDV1R. A control vector with the same expression setup was made by 
replacing the gdv1 cds with a fragment encoding amino acids M173 to N311 of the ApiAP2 
DNA-binding protein SIP2 (45). This fragment was first ligated into pETA-HS (resulting in 
pETA-HS-SIP2) using the SfoI and XhoI restriction sites and the XhoI-digested sip2 PCR product 
amplified from 3D7 gDNA with primers SIP2F and SIP2R. Next, the pStrep-HP1_HS-SIP2 co-
expression vector was Gibson assembled using two PCR products representing (1) the pStrep-
HP1_HS-GDV1 vector omitting the gdv1 cds (amplified using primers SHHSF and SHHSR); and 
(2) the sip2 cds fragment amplified from pETA-HS-SIP2 using primers SIP2F2 and SIP2R2. 
After cloning in E. coli DH5alpha and DNA sequencing, the plasmids were transformed into 
Rosetta2(DE3) cells (Novagen) for recombinant protein expression. 
Recombinant proteins were expressed by auto-induction at 25°C (46). Once the cultures 
were grown to saturation, the bacteria were spun down and pellets frozen. Stock solutions for 
chromatography were 3 M arginine phosphate (3 M L-arginine, 1.6 M H3PO4, pH 7.3), 4 M 
imidazole phosphate (4 M imidazole, 0.888 M H3PO4), 4 M ammonium phosphate (2.8 M 
(NH4)2HPO4, 1.2 M (NH4)H2PO4). Recombinant proteins were purified using the following 
strategy: (1) nickel affinity purification: bacterial pellets were thawed, resuspended in buffer Ni-
A (200 mM arginine phosphate, 500 mM NaCl, 20 mM imidazole phosphate, 5 mM 6-
aminocaproic acid, 0.5 mM TCEP, pH 7.2) and lysed by sonication. The lysate was cleared by 
centrifugation and loaded on a 5 ml HisTrap HP column (GE-Healthcare). The column was 
washed with 15 column volumes (CV) of buffer Ni-A and the proteins were eluted using five 
CV-long linear gradient of Ni-A to Ni-B (Ni-A with 400 mM imidazole phosphate). Both the 
Strep(II)-HP1/HisSUMO-GDV1 complex and HisSUMO-SIP2 eluted in the same range of the 
gradient. (2) StrepTactin affinity purification: the nickel column elution obtained from the 
GDV1/HP1 lysate was loaded on a 5 ml StrepTrap HP column (GE Healthcare), washed with ten 
CV of buffer Strep-A (200 mM arginine phosphate, 300 mM ammonium phosphate, 30 mM 
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NaOH, 5 mM 6-aminocaproic acid, 1 mM EDTA, 0.5 mM TCEP, pH 7.4) and eluted using 
buffer Strep-B (400 mM arginine phosphate, 300 mM ammonium phosphate, 5 mM 6-
aminocaproic acid, 1 mM EDTA, 2.5 mM desthiobiotin, 0.5 mM TCEP, pH 7.4). To purify 
Strep(II)-HP1 without interaction partner, the nickel column flow through obtained from the 
SIP2-HP1 control lysate was used and purified using the same conditions. (3) Hydrophobic 
interaction chromatography: the salt concentration of the StrepTactin column elutions were 
adjusted to 0.75 M ammonium phosphate and loaded on a 1 ml Phenyl HP column (GE 
Healthcare). The column was washed using ten CV of buffer HIC-A (400 mM arginine 
phosphate, 750 mM ammonium phosphate, 5 mM 6-aminocaproic acid, 1 mM EDTA, 0.5 mM 
TCEP, pH 7.2) and the proteins were eluted using a 25 CV-long linear gradient of buffer HIC-A 
to HIC-B (400 mM arginine phosphate, 5 mM 6-aminocaproic acid, 1 mM EDTA, 50 % (w/v) 
ethylene glycol, 0.5 mM TCEP, pH 7.2). The Strep(II)-HP1/HisSUMO-GDV1 complex was 
concentrated using an Amicon spin filter (Millipore) with a 10 K cut-off. Protein samples were 
analysed by SDS/polyacrylamide gel electrophoresis followed by Coomassie staining or Western 
blot analysis. 
All oligonucleotide sequences used for cloning of expression vectors are provided in Table 
S9. 
 
Gametocyte conversion, differentiation and sex ratios 
To quantify sexual conversion rates of 3D7/GDV1-GFP-DD parasites, synchronous 
3D7/GDV1-GFP-DD
OFF
 cultures were split at 8-16 hours post-invasion and one half was 
maintained in the absence of Shield-1 and one half was cultured in the presence of Shield-1 
(3D7/GDV1-GFP-DD
ON
). After re-invasion, parasites were fixed at 38-46 hpi either with 
methanol (Fig. 2B) or 4% formaldehyde/0.0075% glutaraldehyde (Fig. S2) and -Pfs16 IFAs 
combined with DAPI staining was performed to quantify sexual conversion rates (proportion of 
stage I gametocytes among all infected RBCs). To assess gametocyte differentiation, cultures 
were treated with 50 mM N-acetyl-D-glucosamine (GlcNAc) for the first four days after re-
invasion to eliminate asexual parasites (47) and then with normal culture medium for another 4-6 
days when mature stage V gametocytes were observed in Giemsa-stained thin blood smears. 
To quantify male and female gametocytes synchronous 3D7/GDV1-GFP-DD
OFF
 cultures 
were split at 8-16 hours post-invasion and one half was maintained in the absence of Shield-1 
while the other half was cultured in the presence of Shield-1 (3D7/GDV1-GFP-DD
ON
). After re-
invasion, parasites were treated with 50 mM GlcNAc as above. Gametocytaemia was determined 
four days after re-invasion by visual inspection of Giemsa-stained blood smears and used to 
calculate the sexual conversion rate (gametocytaemia observed on day four in relation to the total 
parasitaemia observed on day one after re-invasion). Eleven days after re-invasion male and 
female gametocytes were quantified by inspection of Giemsa-stained blood smears as described 
elsewhere (48) (for each population three individual blood smears were scored blindly). 
To assess 3xHA-GDV1 expression under growth conditions that either suppress or induce 
sexual commitment, 3D7/3xHA-GDV1 parasites were split at 24-30 hours post-invasion and 
pulsed with defined minimal fatty acid medium (RPMI-1640 medium, 25 mM HEPES, 24 mM 
sodium bicarbonate, 100 M hypoxanthine, 0.39% fatty acid-free BSA (Sigma-Aldrich), 30 M 
oleic acid, 30 M palmitic acid), either supplemented with 2 mM choline (suppresses sexual 
commitment) or lacking choline (induces sexual commitment), respectively (16). Twelve hours 
after pulsing relative 3xHA-GDV1 expression levels were determined by Western blot and IFAs 
were performed to determine the proportion of parasites expressing 3xHA-GDV1 in haemozoin-
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positive parasites (1n-4n). Sexual conversion rates were determined as described above by visual 
inspection of Giemsa-stained blood smears after GlcNAc treatment. 
To quantify sexual conversion rates of 3D7/AP2-G-GFP-DDglmS and 3D7/AP2-G-GFP-
DDglmS/gdv1-asKO parasites, synchronous cultures were split at 24-32 hours post-invasion and 
one half was maintained in the presence of glucosamine/absence of Shield-1 and one half was 
cultured in the absence of glucosamine/presence of Shield-1. Sexual conversion rates were 
determined as described above by -Pfs16 IFAs on methanol-fixed thin smears. 
 
Chromatin immunoprecipitations, high throughput sequencing and data analysis 
3D7/GDV1-GFP-DD
OFF
 parasites were synchronized twice 18 hours apart to obtain a six 
hour growth window (18-24 hpi). At 28-34 hpi cultures were split and one half was maintained in 
the absence of Shield-1 and one half was cultured in the presence of Shield-1 (3D7/GDV1-GFP-
DD
ON
). Paired samples of 3D7/GDV1-GFP-DD
OFF
 and 3D7/GDV1-GFP-DD
ON 
parasites were 
harvested at three consecutive time points (TPs) two (30-36 hpi, TP1), six (34-40 hpi, TP2) and 
ten (38-44 hpi, TP3) hours after addition of Shield-1  by crosslinking with 1% formaldehyde for 
15 min at 37ºC. The crosslinking reaction was quenched by 0.125 M glycine. Nuclei were 
isolated by releasing parasites from infected RBCs using 0.05% saponin followed by lysis in 
CLB (20 mM Hepes, 10 mM KCl, 1 mM EDTA, 1 mM EGTA, 0.65% NP-40, 1 mM DTT, 1x 
protease inhibitor (Roche Diagnostics)). Nuclei were washed and snap-frozen in CLB 
supplemented with 50% glycerol. Nuclei were resuspended in sonication buffer (50 mM Tris pH 
8, 1% SDS, 10 mM EDTA, 1x protease inhibitor (Roche Diagnostics)) and sonicated for 20 
cycles of 30 sec ON/30 sec OFF (setting high, Bioruptor
TM
 Next Gen, Diagenode). Fragment 
sizes ranged from 100-600 bp as determined by de-crosslinking a 50 l aliquot and running the 
purified DNA on a 1% agarose gel. ChIPs were performed under rotation overnight at 4°C in 
incubation buffer (5% Triton-X-100, 750 mM NaCl, 5 mM EDTA, 2.5 mM EGTA, 100 mM 
Hepes pH 7.4) by combining sonicated chromatin (500 ng DNA content) with either 1 g mouse 
mAb GFP (Roche Diagnostics #11814460001) or 1 g rabbit PfHP1 (7) in the presence of 
10 l protA and 10 l protG Dynabeads (Life Technologies, #10008D and #10009D). Beads 
were washed for 5 min at 4°C while rotating with 400 l of the following wash buffers: 2x wash 
buffer 1 (0.1% SDS, 0.1% DOC, 1% Triton-X100, 1 mM EDTA, 0.5 mM EGTA, 20 mM Hepes 
pH 7.4), 1x wash buffer 2 (0.1% SDS, 0.1% DOC, 1% Triton-X100, 500 mM NaCl, 1 mM 
EDTA, 0.5 mM EGTA, 20 mM Hepes pH 7.4), 1x wash buffer 3 (250 mM LiCl, 0.5% DOC, 
0.5% NP-40, 1 mM EDTA, 0.5 mM EGTA, 20 mM Hepes pH 7.4), 2x wash buffer 4 (1 mM 
EDTA, 0.5 mM EGTA, 20 mM Hepes pH 7.4). The immunoprecipitated chromatin was eluted in 
200 l elution buffer (1% SDS, 0.1 M NaHCO3) while rotating for 20 min at RT and de-
crosslinked (1% SDS, 0.1 M NaHCO3, 1 M NaCl) in a 45°C shaking heat-block overnight. In 
parallel, 30 l of sonicated input chromatin was de-crosslinked under the same conditions. The 
DNA was purified using QIAquick MinElute PCR columns (Qiagen) and eight separate GFP 
ChIPs or four separate PfHP1 ChIPs were combined. 
To prepare sequencing libraries 1 ng of input DNA, 1 ng -GFP ChIP DNA or 5 ng -HP1 
ChIP DNA were end repaired, extended with 3′ A-overhangs and ligated to barcoded NextFlex 
adapters (Bio Scientific, #514122) as described (49). Libraries were amplified using an optimized 
KAPA protocol (50) using KAPA HiFi HotStart ready mix (KAPA Biosystems, KM2602), 
NextFlex primer mix (Bio Scientific, #514122) and the following PCR program: 98°C for 2 min; 
four cycles of 98°C for 20 sec, 62°C for 3 min; 62°C for 5 min. Amplified libraries were size-
selected for 225-325 bp (mono-nucleosomes + 125 bp NextFlex adapter) using 2% E-Gel Size 
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Select agarose gels (Invitrogen, #G6610-02) and amplified by PCR for ten cycles using the above 
conditions. Libraries were purified and adapter dimers removed by Agencourt AMPure XP beads 
purification using a 1:1 library:beads ratio (Beckman Coulter, #A63880). ChIP-seq libraries were 
sequenced on the Illumina NextSeq 500 system to generate 75 bp single-end reads (NextSeq 
500/550 High Output v2 kit). Reads were mapped against the P. falciparum 3D7 reference 
genome from PlasmoDB v26 (www.plasmodb.org) using BWA samse (v0.7.12-r1039) and 
filtered to mapping quality ≥15 (SAM tools v1.2). Only uniquely mapped reads (between 3.7 and 
11.5 million reads) were used for further analysis. 
To visualize ChIP-seq data in the UCSC Genome browser, all libraries were normalized to 
the amount of mapped reads per million (RPM). Bedgraph files were generated using bedtools 
(v2.20.1). For log2 ratio tracks HP1 or GDV1-GFP-DD ChIP values were divided by input 
values and log2-transformed. For substraction tracks ChIP values obtained from 3D7/GDV1-
GFP-DD
OFF
 parasites were substracted from those obtained from 3D7/GDV1-GFP-DD
ON
 
parasites. Within the UCSC genome browser tracks were smoothened (10-16) and the windowing 
function was set as ‘mean’. To assess HP1 and GDV1-GFP-DD coverage of individual genes, 
tags were counted for each coding region and offset by +1 to avoid division by zero while 
calculating fold change in coverage. Coding region counts were normalized to the number of 
reads per kb per million mapped reads (RPKM). Genes with very low mapability (input 
RPKM<5) were excluded from further analysis. ChIP-seq enrichment values (ChIP/input) were 
calculated over each coding region.  
 
Microarray experiments and data analysis 
3D7/GDV1-GFP-DD
OFF
 parasites were synchronized twice 16 hours apart to obtain an eight 
hour growth window (16-24 hpi). After re-invasion parasites were synchronised again at 0-8 hpi. 
At 4-12 hpi the culture was split and one half was maintained in the absence of Shield-1 and one 
half was cultured in the presence of Shield-1 (3D7/GDV1-GFP-DD
ON
). For both populations, 
total RNA was isolated in the same cell cycle (generation 1) from trophozoites (T1; 24-32 hpi), 
early schizonts (ES1; 32-40 hpi), late schizonts (LS1; 40-48 hpi), and after re-invasion 
(generation 2) from early ring stages (ER2; 8-16 hpi), late ring stages (LR2; 16-24 hpi), 
trophozoites (T2; 24-32 hpi), early schizonts (ES2; 32-40 hpi). Corresponding samples of 
F12/GDV1-GFP-DD
OFF
 and F12/GDV1-GFP-DD
ON
 parasites were prepared accordingly. RNA 
extraction and cDNA synthesis was carried out as described (51). Cy5-labelled test cDNAs were 
hybridised against Cy3-labelled cDNA reference pool consisting of total RNA obtained from 
3D7 wild-type parasites harvested at five consecutive TPs along intra-erythrocytic parasite 
development (7). Equal amounts of Cy5- and Cy3-labelled samples were hybridised on a P. 
falciparum 8×15K Agilent gene expression microarray (GEO platform ID GPL15130) for 16 
hours at 65°C in an Agilent hybridisation oven (G2545A) (52). Slides were scanned using the 
GenePix scanner 4000B and GenePix pro 6.0 software (Molecular Devices). The raw microarray 
data representing relative transcript abundance ratios between each test sample and the reference 
pool (Cy5/Cy3 log2 ratios) were subjected to lowess normalization and background filtering as 
implemented by the Acuity 4.0 program (Molecular Devices). Flagged features and features with 
either Cy3 or Cy5 intensities lower than two-fold the background were discarded. Log2 ratios for 
multiple probes per gene were averaged. Transcripts showing expression values at all seven 
consecutive paired time points were included for downstream analysis. We performed paired 
two-class Significance Analysis of Microarrays (SAM) (53) to identify genes with significant 
differential expression between 3D7/GDV1-GFP-DD
OFF
 and 3D7/GDV1-GFP-DD
ON
 or 
F12/GDV1-GFP-DD
OFF
 and F12/GDV1-GFP-DD
ON
 parasites, respectively (q-value (fdr) cut-off 
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<0.15; mean fold change cut-off >1.5). Heatmaps were generated using Java Treeview (54). 
Scatterplots were generated using Microsoft Excel. The processed microarray data are listed in 
Table S5 (3D7/GDV1-GFP-DD) and S6 (F12/GDV1-GFP-DD). 
 
RNA-seq library preparation, high throughput sequencing and data analysis 
F12 and F12/gdv1-asKO parasites were synchronized twice 16 hours apart to obtain an eight 
hour growth window. Parasites were harvested at 32-40 hpi and at 40-48 hpi. Total RNA was 
isolated using Ribozol (Amresco) according to the manufacturer’s manual and further purified 
using the RNeasy Plus Mini Kit (Qiagen) for removal of gDNA. Residual gDNA was digested 
with TURBO DNA-free
TM
 DNaseI (Ambion) and the RNA was quantified by NanoDrop. Total 
RNA was polyA-selected using the Oligotex mRNA Mini Kit (Qiagen, #70022) according to 
manufacturer’s instructions. Subsequently, 2 g of polyA-selected total RNA equivalent were 
fragmented by alkaline hydrolysis (5x fragmentation buffer: 200 mM Tris-acetate pH 8.2, 500 
mM potassium acetate, 150 mM magnesium acetate) for 1 min 45 sec at 85°C in a 150 l volume 
and precipitated as previously described (55), followed by two TURBO DNase treatments 
(Ambion, #AM2238) to remove possible remnants of genomic DNA. Further library preparation 
for strand-specific RNA-seq was carried out as described (50). In short, first-strand cDNA 
synthesis was performed with AT-corrected random N9 primers (76% AT) in presence of 0.2 g 
Actinomycin D (Thermo 446 Fisher Scientific) to prevent DNA-dependent second-strand cDNA 
synthesis. To maintain the strand-specific information during second-strand synthesis dTTPs 
were replaced with dUTPs. Resulting double-stranded cDNAs (1.9-3.2 ng) were end-repaired and 
extended with 3’ A-overhangs. After ligation of NextFlex adapters (Bio Scientific, #514122), 
libraries were treated with USER enzyme (NEB, #M5505L) to specifically degrade the dUTP-
containing second strand and subsequently amplified by PCR (98°C for 2 min; 4 cycles of 98°C 
for 20 sec, 62°C for 3 min; 62°C for 5 min) using KAPA HiFi HotStart ready mix (KAPA 
Biosystems, #KM2602) and NEXTflex primer mix (Bio Scientific, #514122). Next, libraries 
were size-selected for 300-400 bp fragments using 2% E-Gel Size Select agarose gels 
(Invitrogen, #G6610-02) and amplified for another 12 cycles using the same conditions as above. 
Subsequent depletion of adapter dimers and library purification was performed using Agencourt 
AMPure XP beads (Beckman Coulter, #A63880) in a 1:1 library beads ratio.  
Strand-specific RNA-seq libraries were sequenced on the Illumina NextSeq 500 system to 
generate 75 bp single-end reads (TruSeq SR Cluster Kit v2), which were mapped against the P. 
falciparum 3D7 transcriptome from PlasmoDB v26 using BWA samse (version 0.7.12-r1039). 
Reads were filtered for mapping quality ≥15 (samtools version 1.2) and only uniquely mapped 
reads (between 1.6 and 4.7 million reads) were used for further analysis. After separating the 
reads according to the strand they mapped to (sense strand FLAG16, antisense strand FLAG0), 
sense and antisense transcript abundance was assessed by counting the respective tags for each 
transcript except for transcripts originating from the mitchochondrial and apicoplast genomes. 
Resulting tag counts were offset by +1 and normalized to the number of reads per kb per million 
mapped reads (RPKM). RPKM ratios were calculated when at least one of the two samples per 
time point had a RPKM value ≥ 3. To visualize RNA-seq data in the UCSC Genome browser, 75 
bp reads were additionally mapped against the annotated P. falciparum 3D7 genome (PlasmoDB 
v26), filtered as described above and split into reads mapping to the sense strand (FLAG16) and 
antisense strand (FLAG0), respectively. RNA-seq libraries were normalized to the number of 
mapped reads per million (RPM) and bedgraph files were generated (bedtools v2.20.1). After 
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uploading the tracks to the UCSC genome browser, tracks were smoothened (5) and the 
windowing function was set as ‘mean’. 
 
 
 
Reverse transcription quantitative PCR (RT-qPCR) 
F12 and F12/gdv1-asKO parasites were synchronized twice 16 hours apart to obtain an eight 
hour growth window. Parasites were harvested at 40-48 hpi. Total RNA was isolated using 
Ribozol (Amresco) according to the manufacturer’s manual and further purified using the 
RNeasy Plus Mini Kit (Qiagen) for removal of gDNA. Residual gDNA was digested with 
TURBO DNA-free
TM
 DNaseI (Ambion) and the RNA was quantified by NanoDrop. All samples 
were tested negative for contaminating gDNA by qPCR. 2 g total RNA was reverse-transcribed 
using the RETROscript Kit (Ambion). qPCR reactions were performed at primer concentrations 
of 0.5 M using Power SYBR® Green PCR Master Mix (Applied Biosystems) on a 
StepOnePlus
TM
 Real-Time PCR System (Applied Biosystems) in a reaction volume of 20 l. All 
reactions were run in triplicate yielding virtually identical Ct values. Cycling conditions were: 
95°C for 10 min, followed by 40 cycles of 95°C/15 sec and 60°C/1 min. Product-specific 
amplification was ensured by melting curve analysis for each reaction. Relative transcript levels 
were calculated by normalization against the house-keeping gene encoding eukaryotic translation 
initiation factor 2-alpha kinase (pk4, PF3D7_0628200). All primer sequences are listed in Table 
S9. 
 
 
Supplementary Text 
 
Deletion of the gdv1 asRNA locus in F12 parasites resulted in a marked increase in ap2-g 
transcript levels (Fig. 4B, Fig. S6 and Table S8). Hence, to be able to knock-out the gdv1 asRNA 
in 3D7 parasites we first had to modify the ap2-g locus such that AP2-G expression is prevented 
under default culture conditions. To achieve this in a most robust way we placed expression of 
AP2-G under control of two conditional expression systems. Using a single CRISPR/Cas9-based 
gene editing step we tagged AP2-G with a C-terminal GFP-DD tag and at the same time inserted 
a glmS riboswitch element into the 3’ untranslated region (Fig. S8). The glmS riboswitch allows 
regulating gene expression at the level of the mRNA; in presence of the amino sugar glucosamine 
(GlcN) the glmS ribozyme structure mediates self-cleavage of the mRNA leading to its 
degradation (56-58). As expected, parasites did not express AP2-G-GFP-DD and failed to 
produce gametocytes when cultured in absence of Shield-1 and presence of GlcN. In presence of 
Shield-1 and absence of GlcN AP2-G-GFP-DD expression was detectable by IFA in the nuclei of 
some parasites and gametocytes were produced at a rate of 11.0% (+/- 0.3 SD) (Fig. S8). 
Having established this conditional AP2-G loss-of-function mutant we next deleted the gdv1 
asRNA locus in these parasites (3D7/AP2-G-GFP-DDglmS/gdv1-asKO). 3D7/AP2-G-GFP-
DDglmS/gdv1-asKO parasites still failed to produce gametocytes when AP2-G-GFP-DD 
expression was prevented in absence of Shield-1 and presence of GlcN. However, compared to 
the 3D7/AP2-G-GFP-DDglmS control line 3D7/AP2-G-GFP-DDglmS/gdv1-asKO parasites 
displayed a substantially increased sexual conversion rate of 39.3% (+/- 2.8 SD) when AP2-G-
GFP-DD expression was stabilised, showing that the gdv1-asRNA antagonises the GDV1-
dependent induction of gametocyte conversion. 
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Fig. S1. GDV1 co-localises and interacts with HP1. (A) -GFP (green) and -HP1 (red) co-
localisation IFAs in 3D7/GDV1-GFP-DD
ON
 trophozoites (T, 24-32 hpi), early schizonts (ES, 32-
40 hpi) and late schizonts (LS, 40-48 hpi). Scale bar, 2.5 m. White frames refer to the magnified 
views in the rightmost images (scale bar, 0.5 m). DIC, differential interference contrast. Results 
are representative of three biological replicate experiments. (B) Flow chart of the purification 
approach used to demonstrate direct protein-protein interaction between GDV1 and HP1 co-
expressed in E.coli as HisSumo-tagged GDV1 and Strep(II)-tagged HP1. Co-expression of a 
HisSUMO-tagged N-terminal fragment of the heterochromatin-associated ApiAP2 factor PfSIP2 
(45) and Strep(II)-tagged HP1 was used as negative control. Samples highlighted in blue are 
shown in the Coomassie-stained polyacrylamide gel shown in panel C. (C) Coomassie-stained 
SDS-polyacrylamide gel. Lane 1: protein size standard. Lanes 2, 3: supernatants (SN) of bacterial 
lysates show co-expression of the respective fusion proteins GDV1/HP1 (lane 2) and SIP2/HP1 
(lane 3) (asterisks). Lanes 4, 5: elution samples obtained after Ni
2+
 affinity purification (HIS E) of 
the GDV1/HP1 SN (lane 4) or the SIP2/HP1 SN (lane 5). Strep(II)-tagged HP1 co-purified 
specifically with HisSUMO-GDV1 (lane 4) but not with HisSUMO-SIP2 (lane 5). Lanes 6, 7: the 
Ni2+ column elution of the GDV1/HP1 sample (containing both HisSUMO-GDV1 and Strep(II)-
HP1) and Ni2+ column flow through of the SIP2/HP1 negative control sample (containing 
Strep(II)-HP1) were further purified using StrepTactin affinity purification followed by 
hydrophobic interaction chromatography (HIC). Analysis of the HIC eluates (HIC E) show that 
HisSUMO-GDV1 co-purified with Strep(II)-HP1 (lane 6). (D) -HP1 and -HIS Western blot 
confirm the identities of HisSUMO-GDV1 and Strep(II)-HP1 in the HIC elution samples.  
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Fig. S2. GDV1 over-expression induces sexual commitment. (A,B) Overview images of IFAs 
performed on formaldehyde/glutaraldehyde-fixed cultures 38-46 hours after re-invasion (day 2) 
using -Pfs16 antibodies, highlighting the large proportion of stage I gametocytes (green) in 
3D7/GDV1-GFP-DD
ON
 (A) compared to 3D7GDV1-GFP-DD
OFF
 (B) parasites. Nuclei were 
stained with DAPI. Scale bars, 15 m (20x magnification) and 5 m (40x magnification). (C) 
Proportion of male and female gametocytes in 3D7/GDV1-GFP-DD
OFF 
and 3D7GDV1-GFP-
DD
OFF
 populations. Results represent the mean of three technical replicates (error bars represent 
SD). Total number of scored gametocytes is shown above the bars. 
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Fig. S3. Generation of the 3D7/3xHA-GDV1 line using CRISPR/Cas9 and expression of 
endogenous 3xHA-GDV1. (A) Schematic maps of the gdv1 locus (PF3D7_0935400) in 3D7 
parasites (top), the pFDon_3xha-gdv1 donor and pB_gC-gdv1-5’ CRISPR/Cas9 transfection 
vectors (center), and the modified gdv1 locus after CRISPR/Cas9-based genome editing in 
3D7/3xHA-GDV1 parasites (bottom). The gdv1 sense transcript and multi-exon antisense 
transcript (24) are indicated by undulated arrows in blue and red, respectively. The nucleotide 
positions of the sgt_gdv1-5’ sgRNA target sequence is indicated (chromosome 9 coordinates). 
The pFDon_3xha-gdv1 donor plasmid contains a 3xha sequence (red) flanked on either side by a 
homology box (HB) (orange) for homology-directed repair. The pB_gC-gdv1-5’ plasmid 
contains expression cassettes for SpCas9 (grey), the sgRNA (purple) and the bsd resistance 
marker (brown). Successful gene editing results in the expression of a N-terminally tagged 
3xHA-GDV1. PCR primer binding sites used to confirm successful gene editing are indicated by 
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arrowheads. (B) PCR on gDNA from 3D7/3xHA-GDV1 and 3D7 wild-type parasites. Primers 
gdvHA_F and gdvHA_R bind to chromosomal sequences outside the HBs and amplify a 1455 bp 
or 1362 bp fragment from the edited or wild-type gdv1 locus, respectively. The gdvHA_F/HA_R 
and HA_F/gdvHA_R primer combinations are specific for the edited locus and amplify 795 bp 
and 765 bp fragments, respectively. (C) -HA (green) and -HP1 (red) co-localisation IFAs in 
3D7/3xHA-GDV1 trophozoites (T, 24-32 hpi) and early schizonts (ES, 32-40 hpi). Scale bar, 2.5 
m. White frames refer to the magnified views in the rightmost images (scale bar, 0.5 m). DIC, 
differential interference contrast. Results are representative of two biological replicate 
experiments. (D) Representative -HA (red) IFAs of 3D7/3xHA-GDV1 parasites cultured in 
presence or absence of 2 mM choline. Nuclei were stained with DAPI. Scale bar, 2.5 m. DIC, 
differential interference contrast. 
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Fig. S4. Induction of GDV1-GFP-DD expression triggers a gametocyte-specific 
transcriptional response. The heatmap shows the temporal gene induction profiles of all 
genes with (1) higher transcript levels in 3D7/GDV1-GFP-DD
ON
 compared to the 3D7 
reference pool (positive log2 Cy5/Cy3 ratio), and (2) greater than 2-fold higher transcript 
levels in 3D7/GDV1-GFP-DD
ON
 vs 3D7/GDV1-GFP-DD
OFF
 (log2 fold change >1) in any two 
of the seven consecutive TPs. HP1-associated genes identified previously (2) and in this study 
(Table S7) are highlighted by red boxes. Early gametocyte genes identified in previous studies  
(7, 8, 17) are highlighted by orange boxes. FC, fold change; gen., generation. T1/ES1/LS1, 
trophozoites, early schizonts, late schizonts in generation 1; ER2/LR2/T2/ES2, early ring stages, 
late ring stages, trophozoites, early schizonts in generation 2. 
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Fig. S5. Increased GDV1 occupancy at heterochromatic domains at all three TPs in 
3D7/GDV1-GFP-DD
ON
 compared to 3D7/GDV1-GFP-DD
OFF
 parasites. ChIP-seq ratio tracks 
display relative enrichment (ChIP/input) of GDV1-GFP-DD (blue) or HP1 (green) along 
chromosome 12 in 3D7/GDV1-GFP-DD
ON
 parasites cultured in the presence of Shield-1 for two 
(TP1, 30-36 hpi), six (TP2, 34-40 hpi) or ten hours (TP3, 38-44 hpi) and in the matching control 
populations grown in the absence of Shield-1 (3D7/GDV1-GFP-DD
OFF
). 
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Fig. S6. Generation of the F12/gdv1-asKO parasite line using CRISPR/Cas9. (A) Schematic 
maps of the gdv1 locus (PF3D7_0935400) in F12 parasites (top), the p_gCH-gdv1-asKO 
CRISPR/Cas9 transfection vector (center), and the modified gdv1 locus after CRISPR/Cas9-
based genome editing in F12/gdv1-asKO parasites (bottom). The gdv1 sense transcript and multi-
exon antisense transcript (24) are indicated by undulated arrows in blue and red, respectively. 
The nucleotide positions of the sgt_gdv1-3’ sgRNA target sequence is indicated (chromosome 9 
coordinates). The p_gCH-gdv1-asKO plasmid contains expression cassettes for SpCas9 (grey), 
the sgRNA (purple) and the hdhfr resistance marker (brown) flanked by two homology boxes 
(HB) (orange) for homology-directed repair. PCR primer binding sites used to confirm successful 
gene editing are indicated by arrowheads. (B) PCR on gDNA from F12/gdv1-asKO and F12 
wild-type parasites. Primers gdvF and gdvR bind to chromosomal sequences outside the HBs and 
amplify a 3751 bp or 4818 bp fragment from the edited or wild-type gdv1 locus, respectively. 
The gdvF/hdhfrF and hdhfrR/gdvR primer combinations are specific for the edited locus and 
amplify 1452 bp and 2069 bp fragments, respectively. (C) RT-qPCR data confirming the increase 
in ap2-g and dblmsp2 transcript levels in F12/gdv1-asKO compared to F12 wild-type parasites 
(results are the mean of three biological replicates; error bars represent SD). actin 
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(PF3D7_1264200)/glu-tRNA-l.(PF3D7_1331700), control genes. (D), RT-qPCR showing the 
absence of gdv1 asRNA in F12/gdv1-asKO parasites. Values represent expression levels relative 
to the house-keeping gene encoding eukaryotic translation initiation factor 2-alpha kinase (pk4, 
PF3D7_0628200). glu-tRNA-l. (PF3D7_1331700), control gene. Results are the mean of three 
biological replicates (error bars represent SD). n.d., not detectable. 
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Fig. S7. Generation of the F12/3xHA-GDV1/gdv1-asKO line using CRISPR/Cas9 and 
expression of endogenous 3xHA-GDV1. (A) Schematic maps of the gdv1 locus 
(PF3D7_0935400) in F12/gdv1-asKO parasites (top), the pFDon_3xha-gdv1 donor and pB_gC-
gdv1-5’ CRISPR/Cas9 transfection vectors (center), and the modified gdv1 locus after 
CRISPR/Cas9-based genome editing in F12/3xHA-GDV1/gdv1-asKO parasites (bottom). The 
gdv1 sense transcript is indicated by an undulated arrow in blue. The nucleotide positions of the 
sgt_gdv1-5’ sgRNA target sequence is indicated (chromosome 9 coordinates). The pFDon_3xha-
gdv1 donor plasmid contains a 3xha sequence (red) flanked on either side by a homology box 
(HB) (orange) for homology-directed repair. The pB_gC-gdv1-5’ plasmid contains expression 
cassettes for SpCas9 (grey), the sgRNA (purple) and the bsd resistance marker (brown). 
Successful gene editing results in the expression of a N-terminally tagged 3xHA-GDV1. PCR 
primer binding sites used to confirm successful gene editing are indicated by arrowheads. (B) 
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PCR on gDNA from F12/3xHA-GDV1/gdv1-asKO and F12 wild-type parasites. Primers 
gdvHA_F and gdvHA_R bind to chromosomal sequences outside the HBs and amplify a 1455 bp 
or 1362 bp fragment from the edited or wild-type gdv1 locus, respectively. The gdvHA_F/HA_R 
and HA_F/gdvHA_R primer combinations are specific for the edited locus and amplify 795 bp 
and 765 bp fragments, respectively. (C) -HA (green) and -HP1 (red) co-localisation IFAs in 
F12/3xHA-GDV1/gdv1-asKO trophozoites (T, 24-32 hpi), early schizonts (ES, 32-40 hpi) and 
late schizonts (LS, 40-48 hpi). Scale bar, 2.5 m. White frames refer to the magnified views in 
the rightmost images (scale bar, 0.5 m). DIC, differential interference contrast. Results are 
representative of two biological replicate experiments. 
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Fig. S8. Generation of the 3D7/AP2-G-GFP-DDglmS and 3D7/AP2-G-GFP-DDglmS/gdv1-
asKO parasite lines using CRISPR/Cas9. (A) Schematic maps of the ap2-g locus 
(PF3D7_1222600) in 3D7 parasites (top), the pD_ap2-g-gfp-dd-glmS donor and pH_gC-ap2g-3’ 
CRISPR/Cas9 transfection vectors (center), and the modified ap2-g locus after CRISPR/Cas9-
based genome editing in 3D7/AP2-G-GFP-DDglmS parasites (bottom). The nucleotide positions 
of the sgt_ap2g-3’ sgRNA target sequence is indicated (chromosome 12 coordinates). The 
44 
 
pD_ap2-g-gfp-dd-glmS donor plasmid contains a gfp-dd-glmS fusion sequence flanked on either 
side by a homology box (HB) (orange) for homology-directed repair. The pH_gC-ap2g-3’ 
plasmid contains expression cassettes for SpCas9 (grey), the sgRNA (purple) and the hdhfr 
resistance marker (brown). Successful gene editing results in the expression of a C-terminally 
tagged AP2-G-GFP-DD fusion protein that is under control of the glmS riboswitch system (56). 
PCR primer binding sites used to confirm successful gene editing are indicated by arrowheads. 
(B) Schematic maps of the gdv1 locus (PF3D7_0935400) in 3D7/AP2-G-GFP-DDglmS parasites 
(top), the p_gCB-gdv1-asKO CRISPR/Cas9 transfection vector (center), and the modified gdv1 
and ap2-g loci after CRISPR/Cas9-based genome editing in 3D7/AP2-G-GFP-DDglmS/gdv1-
asKO parasites (bottom). The gdv1 sense transcript and multi-exon antisense transcript (24) are 
indicated by undulated arrows in blue and red, respectively. The nucleotide positions of the 
sgt_gdv1-3’ sgRNA target sequence is indicated (chromosome 9 coordinates). The p_gCB-gdv1-
asKO plasmid contains expression cassettes for SpCas9 (grey), the sgRNA (purple) and the bsd 
resistance marker (brown) flanked by two homology boxes (HB) (orange) for homology-directed 
repair. PCR primer binding sites used to confirm successful gene editing are indicated by 
arrowheads. (C) PCR on gDNA from 3D7/AP2-G-GFP-DDglmS/gdv1-asKO, 3D7/AP2-G-GFP-
DDglmS and 3D7 wild-type parasites. Primers apF and apR bind to chromosomal sequences 
outside the ap2-g HBs and amplify a 2584 bp or 1263 bp fragment from the edited or wild-type 
ap2-g locus, respectively. Primers gdvF and gdvR bind to chromosomal sequences outside the 
gdv1 HBs and amplify a 3751 bp or 4818 bp fragment from the edited or wild-type gdv1 locus, 
respectively. The apF/gfpR and apR/gfpF primer combinations are specific for the edited ap2-g 
locus and amplify 882 bp and 1876 bp fragments, respectively. The bsdR/gdvF and bsdF/gdvR 
primer combinations are specific for the edited gdv1 locus and amplify 1378 bp and 2322 bp 
fragments, respectively. (D) Endogenous ap2-g locus in the 3D7/AP2-G-GFP-DDglmS line and 
-GFP IFA showing AP2-G-GFP-DD expression in a late schizont (LS, 40-48 hpi) from a 
3D7/AP2-G-GFP-DDglmS culture grown in presence of Shield-1 and absence of glucosamine 
(GlcN). DIC, differential interference contrast. Scale bar, 2.5 m. Results are representative of 
three biological replicates. (E) Sexual conversion rates in 3D7/AP2-G-GFP-DDglmS and 
3D7/AP2-G-GFP-DDglmS/gdv1-asKO parasites cultured either in presence of GlcN/absence of 
Shield-1 (AP2-G-GFP-DD expression prevented) or absence of GlcN/presence of Shield-1 (AP2-
G-GFP-DD expression permitted) (results are the mean of three biological replicates (>200 
infected RBCs counted per sample); error bars indicate SD). 
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Table S1. Potential HP1-interacting proteins identified by LC-MS/MS in the eluates of 
three independent Co-IP experiments. Gene IDs and annotations have been retrieved from 
PlasmoDB (www.plasmodb.org). This table lists all proteins detected in all three HP1-GFP Co-IP 
eluates (Co-IP Exp#1-3) and undetected in all negative control eluates. Note that for each 
experiment the sequence coverage and number of unique peptides indicated derive from either 
the 2 M arginine or subsequent 2% SDS elution samples, whichever displayed the higher number 
of unique tryptic peptides detected (see also Table S3). Cov, % sequence coverage; Pep, number 
of unique tryptic peptides detected. 
 
  Co-IP Exp#1 Co-IP Exp#2 Co-IP Exp#3 
GeneID Description Cov Pep Cov Pep Cov Pep 
PF3D7_1220900 heterochromatin protein 1 (HP1) 77.82 30 65.79 23 71.43 24 
PF3D7_0935400 gametocyte development protein 1 (GDV1) 43.91 19 9.68 6 22.20 10 
PF3D7_0818200 14-3-3 protein (14-3-3I) 43.89 7 17.94 3 10.31 3 
PF3D7_1451200 conserved Plasmodium protein, unknown function 17.42 24 14.10 14 15.43 21 
PF3D7_1441400 FACT complex subunit SSRP1, putative (FACT-S) 11.46 5 9.49 4 7.91 3 
PF3D7_0517400 FACT complex subunit SPT16, putative (FACT-L) 1.14 1 8.41 8 3.24 3 
PF3D7_1023900 chromodomain-helicase-DNA-binding protein 1 homolog, putative (CHD1) 0.45 1 0.45 1 5.26 12 
PF3D7_1357400 conserved Plasmodium protein, unknown function 1.70 2 3.56 3 3.48 3 
PF3D7_1456000 transcription factor with AP2 domain(s) (ApiAP2) 2.91 4 0.80 1 3.20 3 
 
 
 
Table S2. Potential GDV1-interacting proteins identified by LC-MS/MS in the eluates of 
three independent Co-IP experiments. Gene IDs and annotations have been retrieved from 
PlasmoDB (www.plasmodb.org). This table lists all proteins detected in all three GDV1-GFP-DD 
Co-IP eluates (Co-IP Exp#1-3) and undetected in all negative control eluates (see also Table S4). 
Cov, % sequence coverage; Pep, number of unique tryptic peptides detected. 
 
  Co-IP Exp#1 Co-IP Exp#2 Co-IP Exp#3 
GeneID Description Cov Pep Cov Pep Cov Pep 
PF3D7_0505800 small ubiquitin-related modifier, putative (SUMO) 54 5 46 4 37 2 
PF3D7_1220900 heterochromatin protein 1 (HP1) 50.38 14 28.95 9 23.31 6 
PF3D7_0935400 gametocyte development protein 1 (GDV1) 32.89 19 23.54 10 18.36 9 
PF3D7_1211800 polyubiquitin (PfpUB) 44.62 1 21 1 21 1 
PF3D7_1451200 conserved Plasmodium protein, unknown function 15.82 24 20.81 29 5.72 7 
PF3D7_1023900 chromodomain-helicase-DNA-binding protein 1 homolog, putative (CHD1) 10.16 30 8.74 23 5.44 13 
PF3D7_1027800 60S ribosomal protein L3, putative 3.11 1 3.11 1 3.11 1 
PF3D7_1447000 40S ribosomal protein S2, putative 2.94 1 3.31 1 3.31 1 
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Table S3. Mass spectrometry results of the HP1-GFP co-IP experiments. This file lists all 
proteins and peptides identified by Mascot and Sequest HT searches of the results obtained from 
LC-MS/MS analysis of protein elutions 1 (E1_Arg) and 2 (E2_SDS) obtained after HP1-GFP co-
IP (HP1 Co-IP) or negative control IPs (neg. control). The experiments have been performed in 
three biological replicates (#1-3). The file contains 12 worksheets. (xlsx format). 
 
Table S4. Mass spectrometry results of the GDV1-GFP-DD co-IP experiments. This file lists 
all proteins and peptides identified by Mascot and Sequest HT searches of the results obtained 
from LC-MS/MS analysis of protein elutions (E_SDS) obtained after GDV1-GFP co-IP (GDV1 
Co-IP) or negative control IPs (neg. control). The experiments have been performed in three 
biological replicates (#1-3). The file contains 6 worksheets. (xlsx format). 
 
Table S5. Processed microarray data obtained from 3D7/GDV1-GFP-DD parasites. 
Columns A-B: Gene ID and gene annotation. Column C: HP1 target genes previously identified 
by ChIP-on-chip (2) and in this study (Table S7). Column D: known early gametocyte markers 
(7, 8, 17). Columns E-K: Cy5/Cy3 log2 ratios for all transcripts and seven TPs harvested from 
3D7/GDV1-GFP-DD
OFF
 parasites. Columns L-R: Cy5/Cy3 log2 ratios for all transcripts and 
seven TPs harvested from 3D7/GDV1-GFP-DD
ON
 parasites. Column S-Y: fold change in gene 
expression (log2) in 3D7/GDV1-GFP-DD
ON
 compared to 3D7/GDV1-GFP-DD
OFF
 parasites for 
each of the seven paired TPs. Column Z: mean fold change in gene expression in 3D7/GDV1-
GFP-DD
ON
 compared to 3D7/GDV1-GFP-DD
OFF
 parasites across all seven TPs. Column AA: 
SAM significance q-values (% fdr). Column AB: significantly up-regulated (u) or down-
regulated (d) genes. T1/ES1/LS1, trophozoites, early schizonts, late schizonts in generation 1; 
ER2/LR2/T2/ES2, early ring stages, late ring stages, trophozoites, early schizonts in generation 2. 
(xlsx format). 
 
Table S6. Processed microarray data obtained with F12/GDV1-GFP-DD parasites. Columns 
A-B: Gene ID and gene annotation. Column C: HP1 target genes previously identified by ChIP-
on-chip (2) and in this study (Table S7). Column D: known early gametocyte markers (7, 8, 17). 
Columns E-K: Cy5/Cy3 log2 ratios for all transcripts and seven TPs harvested from F12/GDV1-
GFP-DD
OFF
 parasites. Columns L-R: Cy5/Cy3 log2 ratios for all transcripts and seven TPs 
harvested from F12/GDV1-GFP-DD
ON
 parasites. Column S-Y: fold change in gene expression 
(log2) in F12/GDV1-GFP-DD
ON
 compared to F12/GDV1-GFP-DD
OFF
 parasites for each of the 
seven paired TPs. Column Z: mean fold change in gene expression in F12/GDV1-GFP-DD
ON
 
compared to F12/GDV1-GFP-DD
OFF
 parasites across all seven TPs. Column AA: SAM 
significance q-values (% fdr). Column AB: significantly up-regulated (u) or down-regulated (d) 
genes. T1/ES1/LS1, trophozoites, early schizonts, late schizonts in generation 1; 
ER2/LR2/T2/ES2, early ring stages, late ring stages, trophozoites, early schizonts in generation 2. 
(xlsx format). 
 
Table S7. GDV1-GFP-DD and HP1 ChIP-seq enrichment values. ChIP/input enrichment 
values were calculated over each coding region of the Pf_3D7_v3 reference genome in 
3D7/GDV1-GFP-DD
ON
 and 3D7/GDV1-GFP-DD
OFF
 parasites at TPs 1-3 (30-36 hpi, 34-40 hpi, 
38-44 hpi). Columns A-B: Gene ID and gene annotation. Column C: chromosome number. 
Columns D-E: Nucleotide positions at the start and end of each gene. Column F: HP1-associated 
genes (HP1 ChIP/input >1 in 3D7/GDV1-GFP-DD
OFF
 control parasites at TP3). Column G: 
known early gametocyte markers (7, 8, 17). Columns H-M: GDV1-GFP-DD ChIP/input values 
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for each population and TP. Columns N-P: fold change in GDV1-GFP-DD occupancy between 
parasites cultured in the presence or absence of Shield-1 for each TP. Columns Q-R: HP1 
ChIP/input values for both populations at TP3. Column S: log2 fold change in HP1 occupancy 
between parasites cultured in the presence or absence of Shield-1 for TP3. (xlsx format). 
 
Table S8. Processed RNA-seq data of sense transcripts obtained from F12 wild-type and 
F12/gdv1-asKO parasites. Columns A-B: Gene ID and gene annotations. Column C: HP1 target 
genes previously identified by ChIP-on-chip (2) and in this study (Table S7). Columns D-E: 
RPKM values for early schizonts (32-40 hpi) of F12 wild-type and F12/gdv1-asKO parasites. 
Column F: fold change (FC) in transcript abundance in F12/gdv1-asKO compared to F12 wild-
type early schizonts (32-40 hpi). Columns G-H: RPKM values for late schizonts (40-48 hpi) of 
F12 wild-type and F12/gdv1-asKO parasites. Column I: fold change (FC) in transcript abundance 
in F12/gdv1-asKO compared to F12 wild-type late schizonts (40-48 hpi). Column J: Genes 
consistently up-regulated (up) or down-regulated (down) in both time points in F12/gdv1-asKO 
compared to F12 wild-type parasites. Genes with RPKM values < 3 in both samples per time 
point are highlighted in grey and were excluded from downstream analyses. (xlsx format) 
 
Table S9. Oligonucleotides used in this study. 
 
